City of Hope develops new immunotherapy to treat Covid-19

Scientists at City of Hope in the US have developed a novel immunotherapy that could offer a new treatment pathway for treating Covid-19 and other infections. The immunotherapy leverages natural killer (NK) cells with a specific molecule that can act on the spike protein of the SARS-CoV-2 virus. The study adds to the expertise of City of Hope in utilising CAR T cell therapy, natural killer cells and other immunotherapies to aid in detecting better therapies for cancer and other ailments.